
Alimera Sciences (ALIM) Cash on Hand
Market Cap: $301.29M
Avg Volume: 866.83K
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
How much cash does Alimera Sciences have?
According to Alimera Sciences's latest annual financial reports, the company has a total of $12.09M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.
Additionally, Alimera Sciences holds $- in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.
In total, the company has $12.09M when combining cash and cash equivalents with short-term investments.
On a per-share basis, Alimera Sciences has $0.47 in cash. This metric helps investors understand how much cash the company holds per outstanding share.
The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-89.79M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.
Lastly, the company's cash position has experienced a growth rate of 129.24%, reflecting the increase in cash and cash equivalents over the specified period.
Cash & Cash Equivalents
$12.09M
Short-Term Investments
$-
Cash & Short-Term Investments
$12.09M
Cash Per Share
$0.47
Free Cash Flow
$-89.79M
Cash Growth
129.24%
Alimera Sciences Historical Cash on Hand
Cash on Hand History
The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2023.
Year | Cash on Hand | Change |
---|---|---|
2023 | $12.09M | 129.24% |
2022 | $5.27M | -68.06% |
2021 | $16.51M | 47.31% |
2020 | $11.21M | 18.91% |
2019 | $9.43M | -27.73% |
2018 | $13.04M | -45.81% |
2017 | $24.07M | -22.31% |
2016 | $30.98M | -0.31% |
2015 | $31.07M | -59.48% |
2014 | $76.70M | 507.36% |
2013 | $12.63M | -74.52% |
2012 | $49.56M | 49.70% |
2011 | $33.11M | 16.11% |
2010 | $28.51M | 91.91% |
2009 | $14.86M | -16.88% |
2008 | $17.88M | -14.26% |
2007 | $20.85M | -23.24% |
2006 | $27.16M | N/A |
Related Metrics
Explore detailed financial metrics and analysis for ALIM.